Apolipoprotein A1 gene polymorphisms at the - 75 bp and +83/84 bp polymorphic sites in healthy Omanis compared with world populations

Human Biology

Volumn 76, Issue 2, 2004, Pages 307-312

  Al Yahyaee, Said Ali S ^a   Al Kindi, Mohammed Nasser ^a   Albahrani, Ali Ihsan ^a  

^a Sultan Qaboos University College of Medicine and Health Sciences   (Oman)

Author keywords

Apolipoprotein A1 (apoA1); Omani population

Indexed keywords

APOLIPOPROTEIN A1; CYTOSINE; THYMINE;

ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MALE; NORMAL HUMAN; OMAN; POPULATION;

EID: 3543047985     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2004.0028     Document Type: Article

References (20)

1. Bai, H., K. Saku, R. Liu et al. 1996. Analysis of a new polymorphism in the human apolipoprotein A-I gene: Association with serum lipoprotein levels and coronary heart disease. J. Cardiol. (4):207-212.
2. Heng, C.K, P.S. Low, and N. Saha. 2001. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr. Res. 49(4):514-518.
3. Jeenah, M., A. Kessling, N. Miller et al. 1990. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Molec. Biol. Med. 7(3):233-241.
4. Juo, S.H., D.F. Wyszynski, T.H. Beaty et al. 1999. Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-gene and apolipoprotein A-I levels: A meta-analysis. Am. J. Med. Genet. 82(3):235-241.
5. Kamboh, M.I., C.E. Aston, C.M. Nestlerode et al. 1996. Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apoA-1 and HDL-cholesterol. Atherosclerosis 127(2):255-262.
6. Kamboh, M.I., C.H. Bunker, C.E. Aston et al. 1999. Genetic association of five apolipoprotein polymorphism with serum lipoprotein-lipid levels in African blacks. Genet. Epidemiol. 16(2):205-222.
7. Khodjet El Khil, H., R. Triki Marrakchi, B. Yacoubi Loueslati et al. 2001. Y chromosome microsatellite variation in three populations of Jerba Island (Tunisia). Ann. Hum. Genet. 65(pt. 3):263-270.
8. Minnich, A., G. DeLangavant, J. Lavigne et al. 1995. G → A substitution at position - 75 of the apolipoprotein A-I gene promoter: Evidence against a direct effect on HDL cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 15(10):1,740-1,745.
9. Ordovas, J.M., D. Corella, L.A. Cupples et al. 2002. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. Am. J. Clin. Nutr. 75(1):38-44.
10. Paul-Hayase, H., M. Rosseneu, D. Robinson et al. 1992. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apoAI, apoCIII and apoAIV concentrations. Hum. Genet. 88(4):439-446.
11. Reguero, J.R., G.I. Cubero, A. Batalla et al. 1998. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease. Cardiology 90(3):231-235.
12. Semino, O., G. Passarino, P.J. Oefner et al. 2000. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: A Y chromosome perspective. Science 290(5494):1,155-1,159.
13. Shoulders, C.C., A.R. Kornblihtt, B.S. Munro et al. 1983. Gene structure of human apolipoprotein A1. Nucleic Acids Res. 11 (9):2,827-2,837.
14. Sigurdsson, G., Jr., V. Gudnason, G. Sigurdsson et al. 1992. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler. Thromb. 12(9):1,017-1,022.
15. Srivastava, R.A., and N. Srivastava. 2000. High density lipoprotein, apolipoprotein A, and coronary artery disease. Molec. Cell Biochem. 209(1-2):131-144.
16. Talmud, P.J., S. Ye, and S.E. Humphries. 1994. Polymorphism in the promoter region of the apolipoprotein A1 gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet. Epidemiol. 11(3):265-280.
17. Wang, X.L., R. Badenhop, K.E. Humphrey et al. 1996. New MspI polymorphism at + 83 bp of the human apolipoprotein AI gene: Association with increased circulating high density lipoprotein cholesterol levels. Genet. Epidemiol. 13(1):1-10.
18. Wang, X.L., S.X. Liu, R.M. McCredie et al. 1996. Polymorphisms at the 5′ end of the apolipoprotein AI gene and severity of coronary artery disease. J. Clin. Invest. 98(2):372-377.
19. Wu, J.H., J.T. Kao, M.S. Wen et al. 2000. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: Correlation of plasma APOCIII with triglyceride level and body mass index. J. Formosa Med. Assoc. 99(5):367-374.
20. Xu, C.F., F. Angelico, M. Del Ben et al. 1993. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet. Epidemiol. 10(2):113-122.